feed,title,long_url,short_url
SeekingAlpha,Week In Review: VistaGen Out-Licenses China/Asia Rights For Novel Anxiety Drug To EverInsight In $177 Million Deal,https://seekingalpha.com/article/4356016,
SeekingAlpha,CrossAmerica Partners: Strong Possibility Of A Distribution Cut,https://seekingalpha.com/article/4356015,
